Danqing D Feng

Title: **Innovative Contributions of Danqing D Feng in Insulin Delivery Systems**

Introduction

Danqing D Feng is a notable inventor residing in Branchburg Township, NJ, who has made significant strides in the field of biopharmaceuticals, specifically focusing on insulin delivery systems. With a total of 31 patents credited to his name, Feng's work continues to pave the way for innovations in diabetes treatment.

Latest Patents

Feng's latest patents include groundbreaking inventions such as "Conjugate Based Systems for Controlled Insulin Delivery" and "Glucose Responsive Insulin Comprising a Tri-valent Sugar Cluster for Treatment of Diabetes." The first patent discusses conjugates that consist of insulin molecules conjugated to multiple separate ligands, each containing a saccharide. This inventive framework allows for insulin to be administered in a manner sensitive to serum concentrations, potentially enhancing its efficacy. In his second patent, the insulin conjugate featuring a tri-valent sugar cluster demonstrates a pharmacokinetic profile that responds optimally to glucose levels, providing a sophisticated approach to managing diabetes without the need for exogenous binding molecules.

Career Highlights

Danqing D Feng has been associated with prestigious organizations such as Merck Sharp & Dohme Corporation and Merck & Company, Inc., where he has utilized his expertise to further research and development in medicinal chemistry and biopharmaceutical innovations. His contributions have significantly influenced the techniques and technologies used in insulin delivery systems.

Collaborations

Throughout his career, Feng has collaborated with esteemed colleagues, including Tesfaye Biftu and XiaoXia Qian. These partnerships have been instrumental in advancing research efforts and pushing the boundaries of what is possible in the field of diabetes treatment.

Conclusion

Danqing D Feng's innovative work in insulin delivery showcases a commitment to improving the lives of those affected by diabetes. His ongoing contributions through patents and collaborations reflect a dedication to advancing medical science and providing new solutions for patients worldwide. As the field of biopharmaceuticals continues to evolve, Feng's inventions are likely to play a critical role in shaping the future of diabetes management.